scholarly article | Q13442814 |
P50 | author | Yiangos Yiangou | Q54918231 |
P2093 | author name string | A P Ford | |
N S Williams | |||
C H Knowles | |||
C L Chan | |||
P Anand | |||
P Facer | |||
P A Baecker | |||
P2860 | cites work | Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. | Q53803625 |
Molecular characterization and pharmacological properties of the human P2X3 purinoceptor | Q24317223 | ||
Glial-derived neurotrophic factor in human adult and fetal intestine and in Hirschsprung's disease | Q28307350 | ||
Ion channels of nociception. | Q33547278 | ||
Connections between P2 purinoceptors and capsaicin-sensitive afferents in the intestine and other tissues | Q33709273 | ||
State-dependent cross-inhibition between transmitter-gated cation channels. | Q33913054 | ||
ATP receptor-mediated synaptic currents in the central nervous system | Q34250363 | ||
A P2X purinoceptor expressed by a subset of sensory neurons | Q34296113 | ||
Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons | Q34296118 | ||
The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. | Q40992725 | ||
GDNF and its receptor component Ret in injured human nerves and dorsal root ganglia | Q41042287 | ||
Distinct ATP receptors on pain-sensing and stretch-sensing neurons. | Q41109141 | ||
Nucleotide receptors | Q41541504 | ||
P2X receptor immunoreactivity in the male genital organs of the rat. | Q42489657 | ||
ATP mediates fast synaptic transmission in mammalian neurons | Q44223096 | ||
Ectopic purinergic sensitivity develops at sites of chronic nerve constriction injury in rat. | Q48097793 | ||
The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system | Q48110278 | ||
Purinergic sensory neurotransmission in the urinary bladder: an in vitro study in the rat. | Q52864988 | ||
P433 | issue | 4 | |
P921 | main subject | inflammation | Q101991 |
inflammatory bowel diseases | Q917447 | ||
P304 | page(s) | 365-369 | |
P577 | publication date | 2001-08-01 | |
P1433 | published in | Neurogastroenterology and Motility | Q15767493 |
P1476 | title | ATP-gated ion channel P2X(3) is increased in human inflammatory bowel disease | |
P478 | volume | 13 |
Q39995014 | A common variant association study reveals novel susceptibility loci for low HDL-cholesterol levels in ethnic Arabs |
Q35177799 | Acid sensing by visceral afferent neurones |
Q35178189 | Acid-sensitive ion channels and receptors |
Q35874789 | Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis |
Q36182806 | Adenosine 5'-triphosphate and its relationship with other mediators that activate pelvic nerve afferent neurons in the rat colorectum. |
Q51753894 | Alteration of neuromuscular transmissions in the hamster colon following the resolution of TNBS-induced colitis. |
Q39848697 | Altered expression of P2X3 in vagal and spinal afferents following esophagitis in rats |
Q34430380 | Altered purinergic signaling in colorectal dorsal root ganglion neurons contributes to colorectal hypersensitivity |
Q44297261 | Analysis of purinergic and cholinergic fast synaptic transmission to identified myenteric neurons. |
Q33235278 | COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord |
Q35952737 | Cellular distribution and functions of P2 receptor subtypes in different systems |
Q38003084 | Characterizing the presence and sensitivity of the P2X7 receptor in different compartments of the gut. |
Q33723148 | Deletion of P2X3 receptors blunts gastro-oesophageal sensation in mice. |
Q33739750 | Development, plasticity and modulation of visceral afferents |
Q50474508 | Developmental regulation of neuron-specific P2X3 receptor expression in the rat cochlea. |
Q46537534 | Differential chemosensory function and receptor expression of splanchnic and pelvic colonic afferents in mice. |
Q85274821 | Differential effects of experimental ulcerative colitis on P2X7 receptor expression in enteric neurons |
Q46352163 | Distribution of P2X(3) receptor immunoreactivity in myenteric ganglia of the mouse esophagus |
Q35947915 | Drug management of visceral pain: concepts from basic research |
Q34041398 | Effects of protein deprivation and re-feeding on P2X2 receptors in enteric neurons. |
Q35047062 | Enteric P2X receptors as potential targets for drug treatment of the irritable bowel syndrome |
Q37377260 | From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease |
Q35522364 | Functional abdominal pain. |
Q35753361 | Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets |
Q38151805 | Gastrointestinal sensitivity and gastroesophageal reflux disease. |
Q55004136 | Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons. |
Q37330911 | Introduction and perspective, historical note |
Q37833525 | Ion channels in inflammation |
Q24617046 | Molecular and functional properties of P2X receptors--recent progress and persisting challenges |
Q35738609 | Neuropharmacology of purinergic receptors in human submucous plexus: Involvement of P2X₁, P2X₂, P2X₃ channels, P2Y and A₃ metabotropic receptors in neurotransmission |
Q37229766 | New bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC. |
Q35100294 | New developments in the treatment of functional dyspepsia |
Q38205485 | Novel thiazole derivatives: a patent review (2008 - 2012. Part 2). |
Q40468184 | P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. |
Q28066934 | P2X ion channel receptors and inflammation |
Q48460330 | P2X receptor ligands and pain |
Q36977790 | P2X3 receptor involvement in pain states |
Q35464242 | P2X3 receptors mediate visceral hypersensitivity during acute chemically-induced colitis and in the post-inflammatory phase via different mechanisms of sensitization |
Q37364689 | Pain and inflammatory bowel disease |
Q42027313 | Peripheral and central P2X receptor contributions to colon mechanosensitivity and hypersensitivity in the mouse |
Q36728925 | Peripheral and central mechanisms of visceral sensitization in man. |
Q28237411 | Pharmacology of P2X channels |
Q35209199 | Pharmacology of inflammatory pain: local alteration in receptors and mediators |
Q27000719 | Potential for developing purinergic drugs for gastrointestinal diseases |
Q21261389 | Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course study |
Q24675663 | Protein kinase C regulation of P2X3 receptors is unlikely to involve direct receptor phosphorylation |
Q26738433 | Purinergic Signaling in Gut Inflammation: The Role of Connexins and Pannexins |
Q38886416 | Purinergic Signalling in the Gut. |
Q33683423 | Purinergic autocrine regulation of mechanosensitivity and serotonin release in a human EC model: ATP-gated P2X3 channels in EC are downregulated in ulcerative colitis |
Q45032136 | Purinergic component of mechanosensory transduction is increased in a rat model of colitis |
Q44642518 | Purinergic mechanisms contribute to mechanosensory transduction in the rat colorectum |
Q36793761 | Purinergic receptors and gastrointestinal secretomotor function |
Q37119870 | Purinergic receptors and synaptic transmission in enteric neurons. |
Q34008598 | Purinergic receptors in gastrointestinal inflammation |
Q26861086 | Purinergic signalling in the gastrointestinal tract and related organs in health and disease |
Q36811213 | Regulation of ATP-gated P2X receptors by phosphoinositides |
Q79960822 | Spontaneous hypersensitivity in mesenteric afferent nerves of mice deficient in the sst2 subtype of somatostatin receptor |
Q92999338 | The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases |
Q35865040 | The Signaling Mechanism of Contraction Induced by ATP and UTP in Feline Esophageal Smooth Muscle Cells |
Q44236293 | The distribution of P2X3 purine receptor subunits in the guinea pig enteric nervous system. |
Q26824817 | The purinergic neurotransmitter revisited: a single substance or multiple players? |
Q38018206 | Treatment of overactive bladder symptoms beyond antimuscarinics: current and future therapies |
Search more.